Aptamer Group plc announced the appointment of Derek Smith as interim chief commercial officer, effective as of 1 January 2023. Derek joined the company in 2018 as Director of Global Sales and has since become a vital part of the Aptamer team, overseeing the development and implementation of the Company's global sales strategy and securing contracts across all three business divisions, including with a number of major pharmaceutical companies. Prior to joining Aptamer Group, Derek held senior sales positions at various UK healthcare companies.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.795 GBX | +2.58% | +9.66% | -30.87% |
May. 22 | Aptamer Group Teams Up with Timser for First-ever Cervical Cancer Blood Test | MT |
May. 22 | Aptamer shares up on GBP465,000 cervical cancer contract with Timser | AN |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-30.87% | 4.61M | |
+6.88% | 33.25B | |
+20.58% | 7.96B | |
+31.37% | 4.25B | |
-29.55% | 2.67B | |
-27.55% | 1.28B | |
-30.53% | 1.2B | |
+11.69% | 999M | |
-35.42% | 902M | |
-20.66% | 686M |
- Stock Market
- Equities
- APTA Stock
- News Aptamer Group plc
- Aptamer Group plc Appoints Derek Smith as Interim Chief Commercial Officer